Location History:
- Montpellier, FR (2015)
- Clapiers, FR (2021 - 2023)
Company Filing History:
4 out of 4 
4 out of 278 
3 out of 1,743 
Years Active: 2015-2025
Title: Muriel Gelin: Innovator in Kinase Inhibitor Technology
Introduction
Muriel Gelin, a prominent inventor based in Clapiers, France, has made significant contributions to the field of medicinal chemistry with her innovative research and development of kinase inhibitors. With a total of four patents to her name, she stands out as a trailblazer in her area of expertise.
Latest Patents
One of Gelin's most notable inventions involves Azaindole derivatives and their use as ERK kinase inhibitors. This cutting-edge patent pertains to a compound of formula (I), or its pharmaceutically acceptable salts, specifically designed for inhibiting ERK kinase activity, particularly ERK2 activity. The significance of this invention lies not only in the primary compounds but also in the associated prodrugs, enhancing their therapeutic applications.
Career Highlights
Throughout her career, Gelin has collaborated with renowned institutions such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. Her work in these organizations has facilitated advancements in the understanding and treatment of various diseases through targeted medication.
Collaborations
Muriel Gelin's success is further enhanced by her collaborations with esteemed colleagues, including Jean-François Guichou and Cédric Bories. These partnerships have fostered an innovative environment, enabling groundbreaking research and development within the pharmaceutical realm.
Conclusion
Muriel Gelin exemplifies the spirit of innovation in the scientific community. Her patents and collaborative efforts in developing effective kinase inhibitors contribute to the ongoing quest for improved therapeutic options. As she continues her work, the potential impact of her inventions remains significant in the landscape of medical science.